Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three TNFRSF1A Mutations Results in Hyperresponsiveness to Lipopolysaccharide

Front Immunol. 2018 Feb 6:9:173. doi: 10.3389/fimmu.2018.00173. eCollection 2018.

Abstract

Tumor necrosis factor (TNF)-receptor-associated periodic fever syndrome (TRAPS) is a rare monogenic autoinflammatory disorder characterized by mutations in the TNFRSF1A gene, causing TNF-receptor 1 (TNFR1) misfolding, increased cellular stress, activation of the unfolded protein response (UPR), and hyperresponsiveness to lipopolysaccharide (LPS). Both microRNA (miR)-146a and miR-155 provide negative feedback for LPS-toll-like receptor 2/4 signaling and cytokine production, through regulation of nuclear factor kappa B (NF-κB). In this study, we hypothesized that proinflammatory cytokine signaling in TRAPS downregulates these two miRs, resulting in LPS-induced hyperresponsiveness in TRAPS dermal fibroblasts (DFs), irrespective of the underlying genetic mutation. Primary DF were isolated from skin biopsies of TRAPS patients and healthy controls (HC). TNFR1 cell surface expression was measured using immunofluorescence. DF were stimulated with LPS, interleukin (IL)-1β, thapsigargin, or TNF, with and without inositol-requiring enzyme 1 (IRE1) inhibitor (4u8C), following which miR-146a and miR-155 expression was measured by RT-qPCR. IL-1β, IL-6, and TNF secretion was measured by enzyme-linked immunosorbent assays, and baseline expression of 384 different miRs was assessed using microfluidics assays. TNFR1 was found to be expressed on the surface of HC DF but expression was deficient in all samples with TRAPS-associated mutations. HC DF showed significant dose-dependent increases in both miR-146a and miR-155 expression levels in response to LPS; however, TRAPS DF failed to upregulate either miR-146a or miR-155 under the same conditions. This lack of miR-146a and miR-155 upregulation was associated with increased proinflammatory cytokine production in TRAPS DF in response to LPS challenge, which was abrogated by 4u8C. Incubation of HC DF with IL-1β led to downregulation of miR-146a and miR-155 expression, which was dependent on IRE1 enzyme. We observed global dysregulation of hundreds of other miRs at baseline in the TRAPS DF. In summary, these data suggest a mechanism whereby IL-1β, produced in response to activation of the UPR in TRAPS DF, downregulates miR-146a and miR-155, by inducing IRE1-dependent cleavage of both these miRs, thereby impairing negative regulation of NF-κB and increasing proinflammatory cytokine production.

Keywords: autoinflammation; inisitol-requiring enzyme 1; lipopolysaccharide; microRNA-146a; microRNA-155; toll-like receptor 4; tumor necrosis factor-receptor-associated periodic syndrome; unfolded protein response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Cytokines / genetics
  • Cytokines / pharmacology
  • Dermis / cytology
  • Down-Regulation
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / genetics*
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects*
  • Fibroblasts / immunology
  • Hereditary Autoinflammatory Diseases / genetics
  • Humans
  • Interleukin-1beta / pharmacology
  • Lipopolysaccharides / pharmacology
  • MicroRNAs / genetics*
  • Mutation
  • Nerve Tissue Proteins / genetics*
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics*
  • Signal Transduction / drug effects
  • Skin / pathology
  • Thapsigargin / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • BABAM2 protein, human
  • Cytokines
  • Enzyme Inhibitors
  • Interleukin-1beta
  • Lipopolysaccharides
  • MIRN146 microRNA, human
  • MIRN155 microRNA, human
  • MicroRNAs
  • Nerve Tissue Proteins
  • Tumor Necrosis Factor-alpha
  • Thapsigargin
  • ERN1 protein, human
  • Protein Serine-Threonine Kinases
  • Endoribonucleases